Pharma Journalist -

Rocket Pharmaceuticals, Inc. announces that it has completed the previously announced acquisition of Renovacor, Inc., a biotechnology company focused on delivering innovative precision…
Read More...

Solid Biosciences Inc. a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), announced the results of the special meeting of the…
Read More...

PTC Therapeutics, Inc. announced that the Brazilian Health Regulatory Agency, ANVISA (Agência Nacional de Vigilância Sanitária), has approved Waylivra (volanesorsen) as the first…
Read More...

TherapeuticsMD, Inc. an innovative, leading women’s healthcare company, today announced that it has entered into definitive agreements to license its products to an affiliate of Mayne…
Read More...

Incyte and CMS Aesthetics, a dermatology medical aesthetic company and subsidiary of CMS announced that the companies have entered into a Collaboration and License Agreement for the…
Read More...

AbCellera and Rallybio Corporation announced that they have entered into a strategic alliance to discover, develop, and commercialize novel antibody-based therapeutics for rare…
Read More...

Hoffmann-La Roche Limited (Roche Canada) announced that it has signed agreements with the Government of Canada to supply 15,000 treatment courses of ACTEMRA  IV (tocilizumab for…
Read More...

Digital health’s deployment has been as fast as it has wide. Over the past 18 months it has become the central focus for health systems, health plans as well as solution providers…
Read More...

BioNTech SE and Ryvu Therapeutics S.A., a clinical-stage company developing oncology therapeutics announced that the companies have entered into a multi-target research collaboration…
Read More...

Biocon Biologics Ltd., a subsidiary of Biocon Ltd. announced today that it has successfully completed its multi-billion-dollar (USD) acquisition of the global biosimilars business of…
Read More...